STAT3 and systemic lupus erythematosus: The use of STAT3 inhibitors in combination with immunosuppressive therapies has been shown to improve SLE by restoring this balance, while agents targeting STAT3 phosphorylation have demonstrated efficacy in treatment [109, 128].